Your browser doesn't support javascript.
loading
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting.
Liu, Yang; Méric, Guillaume; Havulinna, Aki S; Teo, Shu Mei; Åberg, Fredrik; Ruuskanen, Matti; Sanders, Jon; Zhu, Qiyun; Tripathi, Anupriya; Verspoor, Karin; Cheng, Susan; Jain, Mohit; Jousilahti, Pekka; Vázquez-Baeza, Yoshiki; Loomba, Rohit; Lahti, Leo; Niiranen, Teemu; Salomaa, Veikko; Knight, Rob; Inouye, Michael.
Afiliação
  • Liu Y; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: yang.liu2@baker.edu.au.
  • Méric G; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia; Baker Department of Cardiometabolic Health, The University of Melbourne, Mel
  • Havulinna AS; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Institute of Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Teo SM; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Åberg F; Transplantation and Liver Surgery Clinic, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Ruuskanen M; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Department of Internal Medicine, University of Turku, Turku, Finland.
  • Sanders J; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Zhu Q; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Tripathi A; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA, USA; Division of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
  • Verspoor K; School of Computing and Information Systems, University of Melbourne, Melbourne, VIC, Australia; School of Computing Technologies, RMIT University, Melbourne, VIC, Australia.
  • Cheng S; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Jain M; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA, USA; Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA.
  • Jousilahti P; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Vázquez-Baeza Y; Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA; Department of Computer Science & Engineering, Jacobs School of Engineering, University of California, San Diego, La Jolla, CA, USA.
  • Loomba R; NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Lahti L; Department of Computing, University of Turku, Turku, Finland.
  • Niiranen T; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Department of Internal Medicine, University of Turku, Turku, Finland; Division of Medicine, Turku University Hospital, Turku, Finland.
  • Salomaa V; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Knight R; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA, USA; Center for Microbiome Innovation, University of California, San Diego, La Jolla, CA, USA; Department of Computer Science & Engineering, Jacobs School of Engineering, University of California, Sa
  • Inouye M; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia; Baker Department of Cardiometabolic Health, The University of Melbourne, Mel
Cell Metab ; 34(5): 719-730.e4, 2022 05 03.
Article em En | MEDLINE | ID: mdl-35354069
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbiota / Microbioma Gastrointestinal / Hepatopatias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Metab Assunto da revista: METABOLISMO Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbiota / Microbioma Gastrointestinal / Hepatopatias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cell Metab Assunto da revista: METABOLISMO Ano de publicação: 2022 Tipo de documento: Article